#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Corneal neovascularisation Oesophageal carcinoma Homocystinuria Complex regional pain syndrome Cryoglobulinaemia Bronchopulmonary dysplasia Philadelphia chromosome positive Neurofibromatosis Vitamin B12 deficiency Glycogen storage disease type I Behcet's syndrome Marginal zone lymphoma Atypical haemolytic uraemic syndrome Palmar-plantar erythrodysaesthesia syndrome Arterial disorder More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma – Diagnostics Cystic fibrosis lung – Trials in Disease Atypical haemolytic uraemic syndrome – Basic Information Leiomyosarcoma – Basic Information Acute respiratory distress syndrome – Treatment Medulloblastoma – Treatment Niemann-Pick disease – Trials in Disease Anaplastic thyroid cancer – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Synovial sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TETRODOTOXIN Cefixime Ro7790121 RO7284755 Corifollitropin Alfa IBANDRONIC ACID Pegipanermin Cabazitaxel Gedatolisib Lysine Acetate Ly3541860 6QC-ICG Bimatoprost Napabucasin Cibotercept ELTANEXOR Nizatidine ATTR-01 GSKVX000000048111 Savolitinib More therapies…

    Learn about Your Condition

    Pneumococcal infection Drug use disorder Coronary artery occlusion Cardiac valve disease Infertility Herpes zoster Hyponatraemia Cortical dysplasia Sarcoidosis Agitation Nephrogenic anaemia Cervix carcinoma stage I Diabetic retinal oedema Brain neoplasm Hypoglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute graft versus host disease

  • Study Comparing Methylprednisolone and Methoxsalen for Treating Grade II Acute Graft-Versus-Host Disease in Adult Stem Cell Transplant Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Acute graft versus host disease in skin
    Investigated Drugs:
    • Methoxsalen
    • Methylprednisolone Hemisuccinate
    • Posaconazole
    France

  • Study on Mesenchymal Stromal Cells (MC0518) for Treating Steroid-Resistant Acute Graft Versus Host Disease in Adults and Adolescents

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    • Everolimus
    • Mycophenolate Mofetil
    France Germany Poland Spain

  • Study of RLS-0071 in Hospitalized Patients with Steroid-Resistant Acute Graft-versus-Host Disease (aGvHD)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    Investigated Drugs:
    • Ile-Ala-Leu-Ile-Leu-Glu-Pro-Ile-Cys-Cys-Gln-Glu-Arg-Ala-Ala-(Discrete-Polyethylene Glycol)24
    Germany Spain

  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Acute graft versus host disease in intestine
    • Acute graft versus host disease in liver
    Investigated Drugs:
    • Panobinostat
    • Siremadlin
    • Ruxolitinib
    Germany Italy Poland Sweden

  • Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Graft versus host disease
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Cyclophosphamide
    • Mycophenolate Mofetil
    Germany

  • Study on the Safety of ATreg Cells for Patients with Leukemia After Stem Cell Transplant to Reduce Graft vs Host Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Leukaemia
    Investigated Drugs:
    • Allogeneic Cd4+ And Cd25+ T Lymphocytes Ex Vivo Incubated With Gp120
    Germany
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!